Goldman: This Biotech Stock Could Double

CRSP call options are trading at twice the typical pace today

Apr 6, 2018 at 2:12 PM
facebook X logo linkedin


The shares of Crispr Therapeutics AG (NASDAQ:CRSP) are bucking today's broad-market headwinds, thanks to a positive analyst note at Goldman Sachs. Specifically, the brokerage firm launched coverage on the gene editing concern with a "buy" rating and an $86 price target -- more than double yesterday's close -- and waxed optimistic on the company's CRISPR/Cas9 technology. At last check, CRSP shares were up 5% to trade at $44.80, and options traders are rolling the dice on more upside.

Most analysts are already bullish toward Crispr Therapeutics stock, which boasts four "strong buy" ratings, compared to two "holds." Meanwhile, the average 12-month price target of $63.38 represents a premium of 40.8% to the equity's current price, and stands in uncharted territory.

As alluded to above, CRSP calls are trading at three times the average intraday clip, with more than 1,500 contracts already exchanged. Most active is the April 50 call, where it looks like some speculators are buying to open. By purchasing the calls to open, the buyers expect the security to surmount $50 by the close on Friday, April 20, when the options expire.

But just within the past hour there was massive action at the April 45 put, making it the most active option overall today by far. If traders are buying to open the contract, they're expecting the CRSP rally to stall and for the stock to hold below $45 in the weeks ahead.

The shares earlier today peaked at $49.32, and have spent the past several sessions struggling beneath their 40-day moving average. From a longer-term perspective, CRSP stock is still up an impressive 91% year-to-date, and notched an all-time high of $61.24 on March 9.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI